期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 25, 期 22, 页码 5372-5376出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2015.09.029
关键词
HCV; Amidinourea; Guanidine; Hepatitis C life cycle; RNA replication
资金
- Compagnia San Paolo (Italy)
- Medical Research Council - United Kingdom
- Royal Society of Chemistry - United Kingdom
- MRC [MC_UU_12014/2] Funding Source: UKRI
- Medical Research Council [MC_UU_12014/2] Funding Source: researchfish
The discovery of a novel class of HCV inhibitors is described. The new amidinourea compounds were designed as isosteric analogues of the antiviral drug moroxydine. The two derivatives 11g and 11h showed excellent HCV inhibition activity and viability and proved to inhibit a step(s) of the RNA replication. The new compounds have been synthesized in only three synthetic steps from cheap building blocks and in high yields, thus turning to be promising drug candidates in the development of cheaper HCV treatments. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据